RT Journal Article
SR Electronic
T1 Role of renal venous oxygen pressure for renal function monitoring after related living-donor kidney transplantation: cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.15.23291421
DO 10.1101/2023.06.15.23291421
A1 Escarramán-Martínez, Diego
A1 Fernández-Bravo, Montserrat
A1 Kammar-García, Ashuin
A1 Guerrero-Gutiérrez, Manuel Alberto
A1 Meza-Comparán, Héctor David
A1 Mancilla-Galindo, Javier
A1 Sánchez-Díaz, Jesús Salvador
A1 Cendejas-Ríos, Emilio
A1 Escorza-Molina, Carla Adelina
A1 Noriega-Salas, Lorena
A1 Bernaldez-Gómez, Germán
YR 2023
UL http://medrxiv.org/content/early/2023/06/22/2023.06.15.23291421.abstract
AB Introduction Monitoring of renal function after kidney transplantation (KT) is performed by measuring serum creatinine (SCr), urine volumes (UV), and glomerular filtration rate (GFR). Other methods based on oxygen metabolism such as the renal venous oxygen pressure (PrvO2) may be useful. We aimed to explore the correlation between PrvO2 and SCr, UV, and GFR five days after KT (SCr5, UV5, and GFR5, respectively).Methods We conducted a prospective cohort study in adult patients scheduled for living-donor KT. A venous blood sample was taken from the renal vein after declamping the renal artery and blood gas determinations were made. Correlation analyses between PrvO2 and SCr5, UV5, and GFR5, were done by calculating the Spearman correlation coefficient together with generalized linear models (GLM). A Spearman correlation analysis was performed between the percentage decrease in SCr (%ΔSCr) and PrvO2. A GLM was also performed to determine the association of PrvO2 with slow graft function (SGF).Results 42 patients were included; 66.7% were men, and the median age was 31 years (IQR: 27-43.5). PrvO2 was negatively correlated with SCr5 (ρ=-0.53, p=0.003), and positively correlated with GFR5 (ρ=0.49, p=0.001) and %ΔSCr (ρ=0.47, p=0.002). A higher PrvO2 was associated with an increase in GFR in univariable (β=1.24, 95%CI: 0.56-1.93, p=0.001) and multivariable (β=1.24, 95%CI: 0.53-1.94, p=0.001) analyses. No association was found between PrvO2 and SGF.Conclusion PrvO2 could be used to monitor renal function in the first 5 days following related living-donor KT given its good correlation with SCr and GFR.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Ethics and Research Committee of the Instituto Mexicano del Seguro Social gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are openly available in the Harvard Dataverse Repository at https://doi.org/10.7910/DVN/VBCKWO https://doi.org/10.7910/DVN/VBCKWO